Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Tables)

v3.22.1
Net (Loss) Income Per Share (Tables)
6 Months Ended
Mar. 31, 2022
Net (Loss) Income Per Share (Abstract)  
Schedule Of reconciliation of the net income (loss) per basic and diluted common share

Three Months Ended

Six Months Ended

March 31,

March 31,

2022

2021

2022

2021

Net (loss) income

$

(14,177,830)

$

(2,845,981)

$

(20,557,836)

$

14,381,720

Basic weighted average common shares outstanding

80,052,504

75,175,077

80,037,675

72,717,621

Net effect of dilutive instruments:

Stock options

7,147,372

Stock appreciation rights

44,256

Common stock purchase warrants

744,821

Total net effect of dilutive instruments

7,936,449

Diluted weighted average common shares outstanding

80,052,504

75,175,077

80,037,675

80,654,070

Net (loss) income per basic common share outstanding

$

(0.18)

$

(0.04)

$

(0.26)

$

0.20

Net (loss) income per diluted common share outstanding

$

(0.18)

$

(0.04)

$

(0.26)

$

0.18